Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles

<p>Abstract</p> <p>This commentary discusses a study on measurements of matrix metalloproteinase 9 (MMP-9) in serum of pseudoxanthoma elasticum patients recently published in Journal of Molecular Medicine. This study can be considered the typical "obstacle" to effective t...

Full description

Bibliographic Details
Main Authors: Mannello Ferdinando, Jung Klaus, Lein Michael
Format: Article
Language:English
Published: BMC 2009-10-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/7/1/87
id doaj-055e8562ca9b4d96afd82b98a5e9dc53
record_format Article
spelling doaj-055e8562ca9b4d96afd82b98a5e9dc532020-11-25T00:36:39ZengBMCJournal of Translational Medicine1479-58762009-10-01718710.1186/1479-5876-7-87Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principlesMannello FerdinandoJung KlausLein Michael<p>Abstract</p> <p>This commentary discusses a study on measurements of matrix metalloproteinase 9 (MMP-9) in serum of pseudoxanthoma elasticum patients recently published in Journal of Molecular Medicine. This study can be considered the typical "obstacle" to effective translational medicine as previously documented in <it>JTM </it>journal. Although serum has been frequently proven as inappropriate sample for determining numerous circulating MMPs, among them MMP-9, there are over and over again studies, as in this case, that measure MMP-9 in serum. Comparative measurements in serum and plasma samples demonstrated higher concentrations for MMP-9 in serum due to the additional release from leukocytes and platelets following the coagulation/fibrinolysis process. From this example it can be concluded that translating basic research discoveries into clinical tools needs a more intensive exchange between basic biomedical research and clinical scientists already in an early stage. Otherwise a lost of translation, as discussed in <it>JTM </it>journal, seems to be inevitable.</p> http://www.translational-medicine.com/content/7/1/87
collection DOAJ
language English
format Article
sources DOAJ
author Mannello Ferdinando
Jung Klaus
Lein Michael
spellingShingle Mannello Ferdinando
Jung Klaus
Lein Michael
Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles
Journal of Translational Medicine
author_facet Mannello Ferdinando
Jung Klaus
Lein Michael
author_sort Mannello Ferdinando
title Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles
title_short Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles
title_full Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles
title_fullStr Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles
title_full_unstemmed Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles
title_sort translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles
publisher BMC
series Journal of Translational Medicine
issn 1479-5876
publishDate 2009-10-01
description <p>Abstract</p> <p>This commentary discusses a study on measurements of matrix metalloproteinase 9 (MMP-9) in serum of pseudoxanthoma elasticum patients recently published in Journal of Molecular Medicine. This study can be considered the typical "obstacle" to effective translational medicine as previously documented in <it>JTM </it>journal. Although serum has been frequently proven as inappropriate sample for determining numerous circulating MMPs, among them MMP-9, there are over and over again studies, as in this case, that measure MMP-9 in serum. Comparative measurements in serum and plasma samples demonstrated higher concentrations for MMP-9 in serum due to the additional release from leukocytes and platelets following the coagulation/fibrinolysis process. From this example it can be concluded that translating basic research discoveries into clinical tools needs a more intensive exchange between basic biomedical research and clinical scientists already in an early stage. Otherwise a lost of translation, as discussed in <it>JTM </it>journal, seems to be inevitable.</p>
url http://www.translational-medicine.com/content/7/1/87
work_keys_str_mv AT mannelloferdinando translatingmolecularmedicineintoclinicaltoolsdoomedtofailbyneglectingbasicpreanalyticalprinciples
AT jungklaus translatingmolecularmedicineintoclinicaltoolsdoomedtofailbyneglectingbasicpreanalyticalprinciples
AT leinmichael translatingmolecularmedicineintoclinicaltoolsdoomedtofailbyneglectingbasicpreanalyticalprinciples
_version_ 1725304302882258944